References
Key articles
Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64:154-68.Full text Abstract
Squires RH, Ng V, Romero R, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-98.Full text Abstract
Martin P, DiMartini A, Feng S, et al; AASLD. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-65.Full text Abstract
Reference articles
1. Ohi R, Masaki N. The jaundiced infant: biliary atresia and other obstructions. In: O'Neill JA, Rowe MI, Grosfeld JL, et al, eds. Pediatric surgery, 5th ed. St Louis, MO: Mosby; 1998:1465-1482.
2. Balistreri WF, Grand R, Hoofnagle JH, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology. 1996 Jun;23(6):1682-92.Full text Abstract
3. Harpavat S, Garcia-Prats JA, Shneider BL. Newborn Bilirubin Screening for Biliary Atresia. N Engl J Med. 2016 Aug 11;375(6):605-6.Full text Abstract
4. Silveira TR, Salzano FM, Howard ER, et al. Congenital structural abnormalities in biliary atresia: evidence for etiopathogenic heterogeneity and therapeutic implications. Acta Paediatr Scand. 1991;80:1192-1199. Abstract
5. Karrer FM, Hall RJ, Lilly JR. Biliary atresia and the polysplenia syndrome. J Pediatr Surg. 1991;26:524-527. Abstract
6. Jacquemin E, Cresteil D, Raynaud N, et al. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr. 2002;34:326-327. Abstract
7. Kataria R, Kataria A, Gupta DK. Spectrum of congenital anomalies associated with biliary atresia. Indian J Pediatr. 1996;63:651-654. Abstract
8. Casey B. Genetics of human situs abnormalities. Am J Med Genet. 2001;101:356-358. Abstract
9. Davenport M, Tizzard SA, Underhill J, et al. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr. 2006;149:393-400. Abstract
10. Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr. 1993;16:111-113. Abstract
11. Cavallo L, Kovar EM, Aqul A, et al. The epidemiology of biliary atresia: exploring the role of developmental factors on birth prevalence. J Pediatr. 2022 Jul;246:89-94.e2.Full text Abstract
12. Tiao MM, Tsai SS, Kuo HW, et al. Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003. J Gastroenterol Hepatol. 2008;23:62-66. Abstract
13. Schreiber RA, Harpavat S, Hulscher JBF, et al. Biliary atresia in 2021: epidemiology, screening and public policy. J Clin Med. 2022 Feb 14;11(4):999.Full text Abstract
14. Yoon PW, Bresee JS, Olney RS, et al. Epidemiology of biliary atresia: a population-based study. Pediatrics. 1997;99:376-382. Abstract
15. Sokol RJ, Mack C, Narkewicz MR, et al. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003;37:4-21. Abstract
16. Ayas MF, Hillemeier AC, Olson AD. Lack of evidence for seasonal variation in extrahepatic biliary atresia during infancy. J Clin Gastroenterol. 1996;22:292-294. Abstract
17. Caton AR, Druschel CM, McNutt LA. The epidemiology of extrahepatic biliary atresia in New York State, 1983-98. Paediatr Perinat Epidemiol. 2004;18:97-105. Abstract
18. Smith BM, Laberge JM, Schreiber R, et al. Familial biliary atresia in three siblings including twins. J Pediatr Surg. 1991;26:1331-1333. Abstract
19. Bezerra JA, Wells RG, Mack CL, et al. Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century. Hepatology. 2018 Sep;68(3):1163-1173.Full text Abstract
20. Antala S, Taylor SA. Biliary atresia in children: update on disease mechanism, therapies, and patient outcomes. Clin Liver Dis. 2022 Aug;26(3):341-54. Abstract
21. Saito T, Terui K, Mitsunaga T, et al. Evidence for viral infection as a causative factor of human biliary atresia. J Pediatr Surg. 2015 Aug;50(8):1398-404. Abstract
22. Lorent K, Gong W, Koo KA, et al. Identification of a plant isoflavonoid that causes biliary atresia. Sci Transl Med. 2015;7:286ra67.Full text Abstract
23. Waisbourd-Zinman O, Koh H, Tsai S, et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 2016 Sep;64(3):880-93.Full text Abstract
24. Zhao X, Lorent K, Wilkins BJ, et al. Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology. 2016 Sep;64(3):894-907.Full text Abstract
25. Silveira TR, Salzano FM, Donaldson PT, et al. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr. 1993;16:114-117. Abstract
26. Kobayashi, H, Puri P, O'Briain DS, et al. Hepatic overexpression of MHC class II antigens and macrophage associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg. 1997;32:590-593. Abstract
27. Hart MH, Kaufman SS, Vanderhoof JA, et al. Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child. 1991;145:302-305. Abstract
28. Danesino C, Spadoni E, Buzzi A. Familial biliary atresia. Am J Med Genet. 1999;85:195. Abstract
29. Ando K, Miyano T, Fujimoto T, et al. Sibling occurrence of biliary atresia and biliary dilatation. J Pediatr Surg. 1996;31:1302-1304. Abstract
30. Cheng G, Tang CS, Wong EH, et al. Common genetic variants regulating ADD3 gene expression alter biliary atresia risk. J Hepatol. 2013;59:1285-1291. Abstract
31. Garcia-Barceló MM, Yeung MY, Miao XP, et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet. 2010;19:2917-2925.Full text Abstract
32. Chen Y, Gilbert MA, Grochowski CM, et al. A genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1. PLoS Genet. 2018 Aug;14(8):e1007532.Full text Abstract
33. Ningappa M, So J, Glessner J, et al. The Role of ARF6 in Biliary Atresia. PLoS One. 2015;10(9):e0138381.Full text Abstract
34. Berauer JP, Mezina AI, Okou DT, et al. Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome. Hepatology. 2019 Sep;70(3):899-910.Full text Abstract
35. Pickett LK, Briggs HC. Biliary obstruction secondary to hepatic vascular ligation in fetal sheep. J Pediatr Surg. 1969;4:95-101. Abstract
36. Klippel CH. A new theory of biliary atresia. J Pediatr Surg. 1972;7:651-654. Abstract
37. Ho CW, Shioda K, Shirasaki K, et al. The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr. 1993;16:53-60. Abstract
38. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis. 2007;27:233-242. Abstract
39. Bezerra JA, Tiao G, Ryckman FC, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet. 2002;360:1653-1659. Abstract
40. Bezerra JA. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia. J Pediatr Gastroenterol Nutr. 2006;43(suppl 1):S23-S29. Abstract
41. Russo P, Rand EB, Haber BA. Diseases of the biliary tree in infancy and childhood. In: Russo P, Ruchelli ED, Piccoli DA, eds. Pathology of pediatric gastrointestinal and liver disease. New York, NY: Springer; 2004:203-236.
42. Silveira TR, Salzano FM, Howard ER, et al. Extrahepatic biliary atresia and twinning. Braz J Med Biol Res. 1991;24:67-71. Abstract
43. Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1982;307:481-84. Abstract
44. Morecki R, Glaser JH, Johson AB, et al. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. Hepatology. 1984;4:1137-42. Abstract
45. Bangaru B, Morecki R, Glaser JH, et al. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest. 1980;43:456-62. Abstract
46. Chardot C, Carton M, Spire-Bendelac N, et al. Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol. 1999;31:1006-1013. Abstract
47. Noorulla F, Dedon R, Maisels MJ. Association of early direct bilirubin levels and biliary atresia among neonates. JAMA Netw Open. 2019 Oct 2;2(10):e1913321.Full text Abstract
48. Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64:154-68.Full text Abstract
49. Park WH, Choi SO, Lee HJ, et al. A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Paediatr Surg. 1997;32:1555-1559. Abstract
50. Moreira RK, Cabral R, Cowles RA, et al. Biliary atresia: a multidisciplinary approach to diagnosis and management. Arch Pathol Lab Med. 2012 Jul;136(7):746-60.Full text Abstract
51. Humphrey TM, Stringer MD. Biliary atresia: US diagnosis. Radiology. 2007;244:845-851. Abstract
52. Azar G, Beneck D, Lane B, et al. Atypical morphologic presentation of biliary atresia and value of serial liver biopsies. J Pediatr Gastroenterol Nutr. 2002;34:212-215. Abstract
53. Zerbini MC, Gallucci SD, Maezono R, et al. Liver biopsy in neonatal cholestasis: a review on statistical grounds. Mod Pathol. 1997;10:793-799. Abstract
54. Lurie M, Elmalach I, Schuger L, et al. Liver findings in infantile cytomegalovirus infection: similarity to extrahepatic biliary obstruction. Histopathology. 1987;11:1171-1180. Abstract
55. Ishak KG. Inherited metabolic diseases of the liver. Clin Liver Dis. 2002;6:455-479,viii. Abstract
56. Deutsch GH, Sokol RJ, Stathos TH, et al. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol. 2001;4:559-563. Abstract
57. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr. 1971;78:180-181. Abstract
58. Witzleben CL. Neonatal liver disease. Monogr Pathol. 1981;22:346-368. Abstract
59. Oppenheimer EH, Esterly JR. Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. J Pediatr. 1975;86:683-689. Abstract
60. Shapira R, Hadzic N, Francavilla R, et al. Retrospective review of cystic fibrosis presenting as infantile liver disease. Arch Dis Child. 1999;81:125-128.Full text Abstract
61. Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta." Hum Pathol. 1982;13:19-24. Abstract
62. Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117:1147-1154. Abstract
63. Maki T, Sumasaki R, Matsui A. Biliary atresia: recent findings. Mass screening for biliary atresia. Jpn J Pediatr Surg. 1999;31:242-246.
64. Mushtaq I, Logan S, Morris M, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ. 1999;319:471-477.Full text Abstract
65. Schreiber RA, Barker CC, Roberts EA, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007;151:659-665. Abstract
67. Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467-474. Abstract
68. Altman RP, Lilly JR, Greenfeld J, et al. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg. 1997;226:348-355.Full text Abstract
69. National Institutes of Health. Consensus development conference statement: liver transplantation - June 20-23, 1983. Hepatology. 1984;4(1 suppl):107S-110S. Abstract
70. Barshes NR, Lee TC, Balkrishnan R, et al. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl. 2005;11:1193-1200.Full text Abstract
71. Tyraskis A, Parsons C, Davenport M. Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy. Cochrane Database Syst Rev. 2018 May 14;5:CD008735.Full text Abstract
72. Karpen SJ, Kelly D, Mack C, et al. Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders. Hepatol Int. 2020 Sep;14(5):677-89.Full text Abstract
73. ClinicalTrials.gov. Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai (EMBARK). ClinicalTrials.gov Identifier: NCT04524390. May 2023 [internet publication].Full text
74. ClinicalTrials.gov. Efficacy and safety of odevixibat in children with biliary atresia who have undergone a kasai HPE. ClinicalTrials.gov Identifier: NCT04336722. Aug 2023 [internet publication].Full text
75. Squires RH, Ng V, Romero R, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-98.Full text Abstract
76. Martin P, DiMartini A, Feng S, et al; AASLD. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-65.Full text Abstract
Use of this content is subject to our disclaimer